Table 1. Change in O3-related mortality between present (2010–2014) and future (2050–2054) time periods under each SSP.
Country or region | Number of cities | Mean change in O3-related mortality, deaths/year (CI) | Change in O3-related mortality, % (% CI) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
SSP1-2.6 | SSP2-4.5 | SSP3-7.0 | SSP5-8.5 | SSP1-2.6 | SSP2-4.5 | SSP3-7.0 | SSP5-8.5 | |||
Australia | 3 | 0 (0−0) | 0 (0−0) | 0(0−0) | 0 (0−0) | – | – | – | – | |
Canada | 26 | 157 (101−215) | 415(271−568) | 441 (284−603) | 323 (209−454) | 46 (30−64) | 120(78−164) | 132 (85−181) | 93(60−131) | |
China | 3 | 59 (19−98) | 115(37−188) | 104 (32−178) | 80(26−136) | 142 (44−233) | 274 (88−448) | 179(56−310) | 168 (54−285) | |
Czech Republic | 1 | −19 (−33 to −5) | 5 (2−9) | 17 (5−28) | 6(2−11) | −59 (−100 to −16) | 16(5−28) | 54 (15−93) | 21 (6−37) | |
Estonia | 4 | 0 (0−0) | 0 (0−0) | 0(0−0) | 0 (0−0) | −98 (−157 to −35) | −2 (−5 to 6) | 4(1−31) | 19(6−37) | |
France | 18 | −78 (−122 to −32) | 8(3−19) | 98 (40−153) | 61 (25−104) | −68 (−107 to −28) | 6(2−16) | 75(31−118) | 40 (17−68) | |
Germany | 12 | −63 (−97 to −29) | 13(6−21) | 78 (37−122) | 28 (12−46) | −64 (−100 to −30) | 14(6−22) | 77(36−121) | 24 (11−40) | |
Greece | 1 | −31 (−69 to 0) | −12 (−26 to 0) | 12 (1−27) | 9(0−21) | −79 (−176 to 0) | −28 (−62 to 0) | 17 (2−63) | 18(0−44) | |
Italy | 13 | −118(−203 to −35) | −35 (−61 to −9) | 59 (17−102) | 45 (13−85) | −83(−144 to −24) | −25 (−43 to −7) | 37(11−67) | 30 (9−57) | |
Japan | 43 | −339(−489 to −201) | 318(187−470) | 614 (366−897) | 320 (185−499) | −35 (−50 to −20) | 32 (19−47) | 64 (38−93) | 31 (18−48) | |
Mexico | 8 | 378(90−661) | 800 (183−1,409) | 1,385 (329−2,433) | 415(87−770) | 44 (10−77) | 93 (21−164) | 160(39−288) | 51 (11−94) | |
Portugal | 6 | −26 (−54 to 0) | 0 (0−3) | 18 (1−37) | 8 (0−17) | −88 (−185 to 0) | 1 (0−9) | 45(4−116) | 26 (0−56) | |
South Africa | 4 | −43 (−62 to −24) | −23 (−34 to −13) | 105(57−158) | 30 (15−59) | −45 (−64 to −24) | −24(−35 to −13) | 97(53−146) | 28 (14−55) | |
South Korea | 7 | −30 (−49 to −10) | 86(29−142) | 188(65−310) | 116(38−193) | −35 (−58 to −12) | 102 (34−167) | 204 (71−339) | 133(43−221) | |
Spain | 47 | −32 (−83 to 0) | 2 (0−5) | 29 (1−74) | 19(0−50) | −81 (−212 to 0) | 5(0−13) | 41 (3−193) | 49(0−129) | |
Sweden | 1 | −4 (−7 to −1) | 0 (0−0) | 4(1−6) | 4(1−6) | −91 (−151 to −29) | 1 (0−7) | 80(25−134) | 64(20−109) | |
Switzerland | 8 | −20 (−33 to −6) | 8(2−13) | 30 (9−52) | 16(5−27) | −70 (−119 to −22) | 28 (9−47) | 104(33−181) | 56 (17−95) | |
Taiwan | 3 | −4 (−8 to 0) | 180 (7−335) | 283 (19−529) | 147(6−279) | −2 (−3 to 0) | 79 (3−146) | 106(8−216) | 76(3−145) | |
UK | 15 | −17(−21 to −12) | 10(8−14) | 30 (22−38) | 18(13−26) | −85(−108 to −64) | 51 (38−68) | 97(72−123) | 82 (60−117) | |
United States | 183 | 273 (183−364) | 2,516 (1,687−3,408) |
2,689 (1,833−3,579) |
2,076 (1,362−2,973) |
8(5−10) | 69 (46−93) | 80(55−106) | 60 (40−87) |
City-level changes in O3-related mortality are aggregated to the country or region level. Values are rounded to the nearest whole number.